315 related articles for article (PubMed ID: 34433456)
21. Competitive Risk Analysis of Prognosis in Older Adults with Sigmoid Colon Adenocarcinoma: A Population-Based Study.
Du R; Guo J; Li J; Lyu J; Lyu L
Cancer Control; 2024; 31():10732748241262184. PubMed ID: 38868954
[TBL] [Abstract][Full Text] [Related]
22. Short-term mortality risks among patients with non-metastatic bladder cancer.
Zhai M; Tang C; Li M; Chen X; Jin Y; Ying X; Tang Z; Wang X; Wu Y; Sun C; Chen K; Guo X
BMC Cancer; 2020 Nov; 20(1):1148. PubMed ID: 33238972
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive prognostic analysis of cause-specific mortality in patients with ovarian serous cystadenocarcinoma using a competing-risks model: a case study of the SEER database.
Chong SM; Li YJ; He Y; Chokkakula S; Ming WK; Leong NC; Zhao QQ; Chen WH; Huang CD; Deng LH; Lyu J
Eur Rev Med Pharmacol Sci; 2023 Nov; 27(22):11143-11155. PubMed ID: 38039046
[TBL] [Abstract][Full Text] [Related]
24. Competing risk analysis of cardiovascular/cerebrovascular death in T1/2 kidney cancer: a SEER database analysis.
Mo X; Zhou M; Yan H; Chen X; Wang Y
BMC Cancer; 2021 Jan; 21(1):13. PubMed ID: 33402111
[TBL] [Abstract][Full Text] [Related]
25. Developing and validating a novel nomogram used a competing-risks model for predicting the prognosis of primary fallopian tube carcinoma: a retrospective study based on the SEER database.
Li C; Li J; Huang Q; Feng X; Zhao F; Xu F; Han D; Lyu J
Ann Transl Med; 2021 Mar; 9(5):378. PubMed ID: 33842599
[TBL] [Abstract][Full Text] [Related]
26. Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study.
Lazarovici J; Dartigues P; Brice P; Obéric L; Gaillard I; Hunault-Berger M; Broussais-Guillaumot F; Gyan E; Bologna S; Nicolas-Virelizier E; Touati M; Casasnovas O; Delarue R; Orsini-Piocelle F; Stamatoullas A; Gabarre J; Fornecker LM; Gastinne T; Peyrade F; Roland V; Bachy E; André M; Mounier N; Fermé C
Haematologica; 2015 Dec; 100(12):1579-86. PubMed ID: 26430172
[TBL] [Abstract][Full Text] [Related]
27. Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study.
Tao Y; Chen H; Liu D; Dai X
Leuk Res; 2021 Dec; 111():106669. PubMed ID: 34333276
[TBL] [Abstract][Full Text] [Related]
28. Competing-Risk Nomograms for Predicting the Prognosis of Patients With Infiltrating Lobular Carcinoma of the Breast.
Xu F; Li C; Li X; Huang Q; Han D; Wang H; Zheng S; Lyu J
Clin Breast Cancer; 2021 Dec; 21(6):e704-e714. PubMed ID: 33846097
[TBL] [Abstract][Full Text] [Related]
29. Model to predict cause-specific mortality in patients with olfactory neuroblastoma: a competing risk analysis.
Liu L; Zhong Q; Zhao T; Chen D; Xu Y; Li G
Radiat Oncol; 2021 Jun; 16(1):103. PubMed ID: 34112184
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in patients with gastric adenocarcinoma using competing-risk analysis: a study of cases in the SEER database.
Zhang X; Yang J; Huang Q; Lyu J
Scand J Gastroenterol; 2019 Aug; 54(8):1015-1021. PubMed ID: 31382800
[No Abstract] [Full Text] [Related]
31. Time Trends in Rates of Hodgkin Lymphoma Histologic Subtypes: True Incidence Changes or Evolving Diagnostic Practice?
Glaser SL; Clarke CA; Keegan TH; Chang ET; Weisenburger DD
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1474-88. PubMed ID: 26215294
[TBL] [Abstract][Full Text] [Related]
32. Competing Risk of Death in Elderly Patients with Newly Diagnosed Stage I Breast Cancer.
Wasif N; Neville M; Gray R; Cronin P; Pockaj BA
J Am Coll Surg; 2019 Jul; 229(1):30-36.e1. PubMed ID: 30930100
[TBL] [Abstract][Full Text] [Related]
33. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
[TBL] [Abstract][Full Text] [Related]
34. Causes of mortality in cases with extra nodal natural killer/T-cell lymphoma, nasal type: A cohort study.
Mei M; Wang Y; Zhang M
PLoS One; 2019; 14(4):e0214860. PubMed ID: 30995261
[TBL] [Abstract][Full Text] [Related]
35. Impact of nonappendiceal cancer-specific death on overall survival: a competing risk analysis.
Wu J; Man D; Wang K; Li L
Future Oncol; 2019 Dec; 15(35):4083-4093. PubMed ID: 31749380
[No Abstract] [Full Text] [Related]
36. Clinical characteristics and prognostic factors of primary extranodal classical Hodgkin lymphoma: a retrospective study.
Yang M; Ping L; Liu W; Xie Y; Aliya ; Liu Y; Nuersulitan R; Zhu J; Wu M; Song Y
Hematology; 2019 Dec; 24(1):413-419. PubMed ID: 30922173
[TBL] [Abstract][Full Text] [Related]
37. Evaluating overall survival and competing risks of survival in patients with early-stage breast cancer using a comprehensive nomogram.
Xu YB; Liu H; Cao QH; Ji JL; Dong RR; Xu D
Cancer Med; 2020 Jun; 9(12):4095-4106. PubMed ID: 32314546
[TBL] [Abstract][Full Text] [Related]
38. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
39. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
[No Abstract] [Full Text] [Related]
40. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
Shen W; Sakamoto N; Yang L
Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]